Logo image of GROW

U.S. GLOBAL INVESTORS INC-A (GROW) Stock Fundamental Analysis

USA - NASDAQ:GROW - US9029521005 - Common Stock

2.565 USD
-0.15 (-5.35%)
Last: 10/10/2025, 8:32:44 PM
2.55 USD
-0.02 (-0.58%)
After Hours: 10/10/2025, 8:32:44 PM
Fundamental Rating

3

Taking everything into account, GROW scores 3 out of 10 in our fundamental rating. GROW was compared to 238 industry peers in the Capital Markets industry. While GROW has a great health rating, there are worries on its profitability. GROW has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GROW had negative earnings in the past year.
In the past year GROW has reported a negative cash flow from operations.
GROW had positive earnings in 4 of the past 5 years.
GROW had a positive operating cash flow in 4 of the past 5 years.
GROW Yearly Net Income VS EBIT VS OCF VS FCFGROW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

1.2 Ratios

GROW's Return On Assets of -0.69% is on the low side compared to the rest of the industry. GROW is outperformed by 78.57% of its industry peers.
GROW's Return On Equity of -0.74% is on the low side compared to the rest of the industry. GROW is outperformed by 74.37% of its industry peers.
Industry RankSector Rank
ROA -0.69%
ROE -0.74%
ROIC N/A
ROA(3y)2.51%
ROA(5y)12.94%
ROE(3y)2.67%
ROE(5y)14.64%
ROIC(3y)N/A
ROIC(5y)N/A
GROW Yearly ROA, ROE, ROICGROW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

GROW does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GROW Yearly Profit, Operating, Gross MarginsGROW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

7

2. Health

2.1 Basic Checks

The number of shares outstanding for GROW has been reduced compared to 1 year ago.
Compared to 5 years ago, GROW has less shares outstanding
Compared to 1 year ago, GROW has a worse debt to assets ratio.
GROW Yearly Shares OutstandingGROW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
GROW Yearly Total Debt VS Total AssetsGROW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

An Altman-Z score of 9.36 indicates that GROW is not in any danger for bankruptcy at the moment.
GROW has a better Altman-Z score (9.36) than 92.44% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that GROW is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.00, GROW belongs to the best of the industry, outperforming 87.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.36
ROIC/WACCN/A
WACCN/A
GROW Yearly LT Debt VS Equity VS FCFGROW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M 40M 50M

2.3 Liquidity

A Current Ratio of 20.87 indicates that GROW has no problem at all paying its short term obligations.
GROW has a Current ratio of 20.87. This is amongst the best in the industry. GROW outperforms 98.32% of its industry peers.
GROW has a Quick Ratio of 20.87. This indicates that GROW is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 20.87, GROW belongs to the best of the industry, outperforming 98.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 20.87
Quick Ratio 20.87
GROW Yearly Current Assets VS Current LiabilitesGROW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for GROW have decreased strongly by -128.19% in the last year.
The Revenue has grown by 67.97% in the past year. This is a very strong growth!
Measured over the past years, GROW shows a quite strong growth in Revenue. The Revenue has been growing by 14.64% on average per year.
EPS 1Y (TTM)-128.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-160.79%
Revenue 1Y (TTM)67.97%
Revenue growth 3Y-32.43%
Revenue growth 5Y14.64%
Sales Q2Q%-29.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GROW Yearly Revenue VS EstimatesGROW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GROW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GROW Price Earnings VS Forward Price EarningsGROW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GROW Per share dataGROW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

GROW has a Yearly Dividend Yield of 3.31%.
GROW's Dividend Yield is comparable with the industry average which is at 8.50.
Compared to an average S&P500 Dividend Yield of 2.44, GROW pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.31%

5.2 History

The dividend of GROW is nicely growing with an annual growth rate of 24.71%!
GROW has been paying a dividend for at least 10 years, so it has a reliable track record.
GROW has decreased its dividend recently.
Dividend Growth(5Y)24.71%
Div Incr Years1
Div Non Decr Years1
GROW Yearly Dividends per shareGROW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1

5.3 Sustainability

GROW has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-361.68%
EPS Next 2YN/A
EPS Next 3YN/A
GROW Yearly Income VS Free CF VS DividendGROW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

More info and screens

U.S. GLOBAL INVESTORS INC-A

NASDAQ:GROW (10/10/2025, 8:32:44 PM)

After market: 2.55 -0.02 (-0.58%)

2.565

-0.15 (-5.35%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)09-11 2025-09-11
Earnings (Next)11-05 2025-11-05
Inst Owners32.22%
Inst Owner Change0%
Ins Owners6.12%
Ins Owner Change1.61%
Market Cap33.24M
Analysts0
Price TargetN/A
Short Float %0.52%
Short Ratio1.82
Dividend
Industry RankSector Rank
Dividend Yield 3.31%
Yearly Dividend0.09
Dividend Growth(5Y)24.71%
DP-361.68%
Div Incr Years1
Div Non Decr Years1
Ex-Date12-15 2025-12-15 (0.0075)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.75
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.68
BVpS3.49
TBVpS3.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.69%
ROE -0.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.51%
ROA(5y)12.94%
ROE(3y)2.67%
ROE(5y)14.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 20.87
Quick Ratio 20.87
Altman-Z 9.36
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.39%
Cap/Sales(5y)1.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-160.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)67.97%
Revenue growth 3Y-32.43%
Revenue growth 5Y14.64%
Sales Q2Q%-29.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y58.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-206.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-183.03%
OCF growth 3YN/A
OCF growth 5YN/A